Virbac, FR0000031577

Virbac Stock - Thursday technical picture and volatility check

18.06.2026 - 20:50:54 | ad-hoc-news.de

Virbac stock trades on Euronext Paris after a muted week, with Thursday’s focus on chart levels and recent volatility rather than fresh corporate news. A look at the 200-day line, trading range and sector backdrop frames the veterinary pharma specialist.

Virbac, FR0000031577
Virbac, FR0000031577

Edited by ad hoc news Chart & Technicals Desk. Verified prior to publication on 06/18/2026, 20:50 CET. Details in the imprint.

Virbac (FR0000031577) is a French veterinary pharmaceutical group whose stock trades on Euronext Paris. With no new company announcements or major analyst actions reported today, Thursday’s view centers on the current trading range and key technical levels for the shares.

Go deeper

All news and key data on Virbac stock

Find additional headlines, price data and background information on Virbac stock in the dedicated topic area and on the company’s Investor Relations pages.

What the charts show today

Virbac shares recently traded around EUR 329.50 on Euronext Paris, with data from a retail platform indicating a daily change of roughly -0.75% and a one-week decline of about 3.4%. Another price snapshot shows the stock near EUR 331.16 in intraday action.

Against this backdrop, the stock is oscillating in a relatively narrow short-term range after prior gains earlier this year, while trading volumes remain typical for a mid-cap French healthcare name. On balance, the pattern suggests a phase of consolidation rather than a strong directional move.

Thursday focus on technicals

For Thursday’s technical lens, investors often watch the 200-day moving average as a rough indicator of longer-term trend, even if exact values vary slightly across data providers. Virbac stock currently trades modestly above its pandemic-era lows and below recent 12-month highs, leaving the medium-term picture mixed.

Shorter-term momentum indicators, such as 14-day relative strength on common chart services, point to neither extreme overbought nor oversold territory, consistent with the muted weekly move. Ultimately, many traders will watch whether the shares can establish a stable base above current levels in coming weeks.

How Virbac makes its money

Virbac generates most of its revenue from veterinary medicines and vaccines for companion animals and livestock, including products for parasiticides, antibiotics, dermatology and nutrition. The group operates manufacturing sites in France and several other countries, serving veterinarians and animal owners globally.

Where the stock trades today

The shares of Virbac (FR0000031577) trade on Euronext Paris at about EUR 329.50 as of 06/18/2026, 20:40 CET.

Key facts on Virbac stock

  • Company: Virbac S.A.
  • ISIN: FR0000031577
  • WKN: 501882
  • Ticker: VIRP
  • Venue: Euronext Paris
  • Price (as of 06/18/2026, 20:40 CET): 329.50 EUR
  • Market cap: approximately 2.8 billion EUR (as of 06/18/2026)
  • Sector / Industry: Health Care - Animal Health / Pharmaceuticals
  • Index membership: not a member of the CAC 40; included in selected French mid-cap and sector indices
  • Next earnings date: not officially scheduled

More on Virbac stock on social media

This article was AI-assisted and editorially reviewed. Price and company data without warranty; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Trading securities involves risk up to total loss of capital.

en | FR0000031577 | VIRBAC | boerse | 69575904 | bgmi